Analyst Price Target for FGEN. Difei maintained her 72 price target and buy rating on FGEN stock. Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! The high price target for FGEN is $72.00 and the low price target for FGEN is $40.00. During the day the stock fluctuated 16.49% from a day low at $33.84 to a day high of $39.42. Jefferies cut FibroGen, Inc. (NASDAQ:FGEN) price target from $75 to $45. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. This price target is based on 5 analysts offering 12 month … The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. Analysts on Wall Street suggest a consensus price target of $54.56, implying an increase of 55.22% to the stock’s current value. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Based on analysts offering 12 month price targets for FGEN in the last 3 months. Dow Jones, a News Corp company About WSJ. View real-time stock prices and stock quotes for a full financial overview. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. FGEN: Get the latest FibroGen stock price and detailed information including FGEN news, historical charts and realtime prices. Over the last 30 days, this security got 2 buy, 0 sell and 2 hold ratings. Start Your Risk-Free Trial Subscription Here, Editor of top German newspaper suspended in compliance probe, Timing key in consulting deal between FirstEnergy, regulator, You Must Recognize Your Own Achievements First Before Expecting Others To, The Latest: Paris may face new lockdown as ICUs fill up, 'Big burden' for schools trying to give kids internet access, The Latest: Pakistan imposes partial lockdown in some areas, Three Mall Retailers For Your Reopening Watchlist, 3 Growth Stocks with Above Market Dividend Yields, 3 Best Stocks to Buy That You’ve Probably Never Heard Of, Ferroglobe Will Get a Big Lift From Demand For Silcon Wafers, Blue Bird Stock is a Dual Tailwinds EV and Re-Opening Play, Nautilus Stock is a Pullback Buying Opportunity Here, The Launch of Truforma Should Send Zomedica to An All-Time High, Defi Markets Pause But New Highs Are In Sight, 7 Stocks That Cathie Wood is Buying And You Should Too, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, Receive Analysts' Upgrades and Downgrades Daily. The … The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . FGEN … SVB Leerink’s price target … According to 5 Wall Street analysts that have issued a 1 year FGEN price target, the average FGEN price target is $65.40, with the highest FGEN stock price forecast at $91.00 … On average, Wall Street analysts predict that Fibrogen's share price could reach $65.40 by Jan 11, 2022. View Price Target for FGEN Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $50.50. Ratings...FREE! Dow Jones, a News Corp company About WSJ. Price Target and Analyst Ratings. Please log in to your account or sign up in order to add this asset to your watchlist. All rights reserved. Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Fibrogen Inc's average analyst price target is greater than 83.51% of Pharmaceutical Products stocks. HC Wainwright’s target price points to a potential upside of 20.38% from the company’s current price. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Identify stocks that meet your criteria using seven unique stock screeners. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. FGEN Stock Summary. Find real-time FGEN - FibroGen Inc stock quotes, company profile, news and forecasts from CNN Business. FGEN has been the subject of a number of analyst reports. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $50.50. First Gen Corp (FGEN:PHS) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. © American Consumer News, LLC dba MarketBeat® 2010-2021. There are currently 1 sell rating, 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Hold.". FGEN has a higher NA than just about none of of all US stocks. Use POWR Ratings for clearer insight into price direction. above. Their average twelve-month price target is $53.57, predicting that the stock has a possible upside of 59.39%. To see all exchange delays and terms of use please see disclaimer. The lighter blue line represents the stock's consensus price target. View real-time stock prices and stock quotes for a full financial overview. Investors may trade in the Pre-Market (4:00-9:30 a.m. Get daily stock ideas top-performing Wall Street analysts. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. As such, FGEN has been trading 104.84% off suggested target … Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. The rating they have provided for FGEN stocks is “Buy” according to the report published on July 10th, 2020. Over the last 30 days, this security got 2 buy, 0 sell and 2 hold ratings. FibroGen (NASDAQ:FGEN) 's stock had its "hold" rating restated by equities research analysts at Jefferies Financial Group in a research report issued to clients and investors on Monday, Benzinga reports. FGEN updated stock price target summary. See what's happening in the market right now with MarketBeat's real-time news feed. See FGEN | Complete FibroGen Inc. stock news by MarketWatch. As such, FGEN has been trading 104.84% off suggested target … SVB Leerink is very positive to FGEN and gave it a "Outperform" rating on March 08, 2021. This … Just click the link Fibrogen Inc's variance in analysts' estimates is lower than 11.3% of all US stocks. 8 Wall Street analysts have issued ratings and price targets for FibroGen in the last 12 months. FGEN has been the subject of a number of analyst reports. Fundamental company data provided by Zacks Investment Research. … FGEN | Complete FibroGen Inc. stock news by MarketWatch. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 appreciate its future potential. Analysts on Wall Street suggest a consensus price target of $54.56, implying an increase of 55.22% to the stock’s current value. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Login 1y Target Est 54.56 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. ET) and the After Hours Market (4:00-8:00 p.m. They currently have an … We have 9 different ratings for every stock to help you The extremes give us $44 and $72 for target low and target high price respectively. FibroGen Stock Forecast, FGEN stock price prediction. FGEN has a greater number of analysts covering the stock than 74.89% of Pharmaceutical Products stocks. FibroGen, Inc. (FGEN… Cowen gave a rating of “Market Perform” to FGEN, setting the target price at $40 in the report published on May 01st of the current year. Jefferies Financial Group lowered FibroGen from a “buy” rating to a “hold” rating and reduced their target price … FGEN's price/sales ratio is 17.52; that's higher than the P/S ratio of 89.36% of US stocks. This price target is based on 7 analysts offering 12 month price targets for FibroGen in the last 3 months. FGEN updated stock price target summary. The average analyst price target of FGEN is greater than 83.51% of Pharmaceutical Products stocks. FibroGen (NASDAQ:FGEN) had its price target reduced by SVB Leerink from $91.00 to $64.00 in a research report sent to investors on Tuesday, Analyst Ratings Network reports. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Use POWR Ratings for clearer insight into price direction. What is FGEN's Price Target? Fibrogen Inc's upside potential (average analyst target price relative to current price) is higher than 82.13% of all US stocks. But SVB Leerink analyst Geoffrey Porges expects the FDA to eventually reject roxadustat. Join. In that case, then, we find that the latest price level in today’s session is +103.56% off the targeted high while a plunge would see the stock lose 24.4% from current levels. Sign Up to See To see all exchange delays and terms of use, please see disclaimer. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Learn about financial terms, types of investments, trading strategies and more. The chart below shows how a company's share price and consensus price target have changed over time. Our Accessibility Statement Do Not Sell My Information. They currently have a $45.00 target price on the biopharmaceutical company's stock, down from their prior target price of $75.00. Price target in 14 days: 30.549 PHP. You can opt out at any time. The dark blue line represents the company's actual price. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Chardan Capital boosted the price target for uniQure … Learn more. Learn everything you need to know about successful options trading with this three-part video course. Just enter your email address below. Their average twelve-month price target is $53.57, predicting that the stock has a possible upside of 52.41%. SVB Leerink lowered their price target … ET). FGEN.PH updated stock price target summary. Enjoy free access to the POWR Ratings for all stocks and ETFs on the quote pages. Want to see which stocks are moving? The extremes give us $44 and $72 for target low and target high price respectively. FibroGen shares fell 22.8% to $39.02 in pre-market trading. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. The projected low price target is $44 while the price target rests at a high of $72. The tables below show price targets and recommendations from analysts covering Fibrogen Inc. Over the past 21 days, FGEN's average price target has gone up $2.62. • 3 Electric Vehicle Supplier Stocks to Consider Adding to Your Portfolio, • Video Game Industry in 2021: The Complete Investors Guide. In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Fibrogen Inc are MCRB, URGN and MRUS. This is 24.66% less than the trading day before Monday, 1st Mar 2021. SVB Leerink is very positive to FGEN and gave it a … All 'A' Rated Buy Stocks. The median FGEN price target (a different metric than the average or mean) was $64.0 as of 2021-02-21, the highest FGEN price target in the range was $91.0 while the lowest FGEN price target in the range was $44.0, with a standard deviation of $16.67. First Gen Stock Forecast, FGEN stock price prediction. The average price target is $59.67, with a high forecast of $92.00 and a low forecast of $40.00. First In Its Class. You can unlock it all now. Price target in 14 days: 53.465 USD. Receive a free world-class investing education from MarketBeat. Close price at the end of the last trading day (Tuesday, 2nd Mar 2021) of the FGEN stock was $38.07. In terms of twelve month growth in earnings before interest and taxes, Fibrogen Inc is … Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. FGEN has a greater … Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for FGEN shares is $62.33 per share. Analysis on target price and performance of … What is the outlook for FGEN? Find real-time FGEN - FibroGen Inc stock quotes, company profile, news and forecasts from CNN Business. View our full suite of financial calendars and market data tables, all for free. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Average Target Price: 62.33: Number Of Ratings: 11: FY Report Date: 12/2020: Last Quarter's Earnings: 0.35: Year Ago Earnings-0.38: Current … The price target was set to $91.00 → $64.00. View which stocks are hot on social media with MarketBeat's trending stocks report. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). FGEN has been the topic of a number of other research reports. Get short term trading ideas from the MarketBeat Idea Engine. According to 5 Wall Street analysts that have issued a 1 year FGEN price target, the average FGEN price target is $65.40, with the highest FGEN stock price forecast at $91.00 and the lowest FGEN stock price forecast at $44.00. … The high price target for FGEN is $72.00 and the low price target for FGEN is $40.00. The stock has a Strong Buy consensus rating, based on a unanimous 5 reviews, and the $16.50 average price target indicates 25% growth potential from the share price of $13.19. SVB Leerink is very positive to FGEN and gave it a "Outperform" rating on March 08, 2021. Dow Jones, a News Corp company About WSJ. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . First Gen Corp (FGEN:PHS) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. A number of other research analysts have also weighed in on the company. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Export data to Excel for your own analysis. FibroGen (NASDAQ:FGEN) had its price objective dropped by analysts at SVB Leerink from $91.00 to $64.00 in a research note issued on Tuesday, Benzinga reports. The price target was set to $91.00 → $64.00. Copyright © 2021. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Learn more. Looking for new stock ideas? The variance in analysts' estimates of FGEN is lower than 11.3% of all US stocks. View Price Target for FGEN Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Based on analysts offering 12 month price targets for FGEN in the last 3 months. 8 Wall Street analysts have issued ratings and price targets for FibroGen in the last 12 months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). SVB Leerink lowered their price target on FibroGen from $91.00 to $64.00 and set an "outperform" rating for the company in a research report on Tuesday, March 2nd. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on FGEN stock is a recommendation set at 2.00.